Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Phosphatidic acid, dioleoyl

PKC activator
 
BML-LP104-0010 10 mg 96.00 USD
Do you need bulk/larger quantities?
 
A mitogenic lipid phosphate produced via the action of phospholipase D. Mediates agonist-dependent Raf-1 translocation and activation of the MAP kinase cascade. Activates PKCζ.

Product Specification

Alternative Name:1,2-Dioleoyl-sn-glycero-3-phosphate . Na
 
Formula:C39H73O8P . Na
 
MW:724
 
CAS:108392-02-5
 
Purity:≥98% (GC)
 
Identity:Determined by IR.
 
Appearance:White powder.
 
Solubility:Soluble in chloroform.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
bml-lp104
Please mouse over
bml-lp104

Product Literature References

The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras: M. A. Rizzo, et al.; J. Biol. Chem. 275, 23911 (2000), Abstract; Full Text
Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway: M. A. Rizzo, et al.; J. Biol. Chem. 274, 1131 (1999), Abstract;
A role for phospholipase D in control of mitogenesis: M. R. Boarder, et al.; Trends Pharmacol Sci. 15, 57 (1994), Abstract;
Phosphatidic acid activation of protein kinase C-zeta overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids: C. Limatola; Biochem. J. 304, 1001 (1994), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
PKC
By biological activity:
PKC Activator
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,